medical research support program

• MyServiceNSW
• Manage account
• Logout of MyServiceNSW

Medical Research Support Program 2024-2028

The NSW Government’s flagship program for eligible independent medical research institutes in NSW. Provides support for the indirect costs of research based on success in competitive National Health and Medical Research Council grant schemes.

Key information

• Status: Closed
• Grant amount: Up to $40,000,000
• Application opened: 13 May 2024
• Application closed: 17 July 2024

Program objective

The Medical Research Support Program provides research infrastructure support funding to eligible independent medical research institutes. Through this investment, NSW Health aims to support the growth of a sustainable and highly productive medical research sector in NSW.

The Medical Research Support Program aims to:

• Support excellence in health and medical research through the delivery of high-quality outputs
• Promote critical mass in health and medical research as part of the effective use of resources
• Monitor and help ensure the financial sustainability of participating institutes.

This program is funded and administered by NSW Health.

Eligibility

To receive funding from the Medical Research Support Program, organisations must demonstrate that they meet ALL eligibility criteria. 

Who can apply

Applicant organisations must:

• be located in NSW
• have health and medical research as their primary purpose
• have organisational independence
• conduct high-quality research at a sufficient scale
• have financial viability.

Who can’t apply

Organisations who do not meet all the eligibility criteria, including

• affiliations of convenience – weakly affiliated research groups that represent themselves as a single entity solely for the purpose of meeting the eligibility criteria
• organisations that facilitate research – research communities representing themselves as research organisations, hubs or consortia
• controlled entities or units of other organisations – research groups that have, for example, a university or health service as their parent entity.

Types of projects funded under this grant

Medical Research Support Program funding can be used for the indirect costs of research only. Recipients will be required to report on expenditure to ensure funds are used for eligible purposes only. 

What can’t you apply for

Medical Research Support Program funding cannot be used to fund research projects or capital works. Funding may not be used to support activity where a statewide asset already exists (e.g. biobanking).

Example projects

Successful applicants from the 2020-2024 Medical Research Support Program round included:

• Black Dog Institute
• Centenary Institute
• Children’s Cancer Institute Australia
• Children’s Medical Research Institute
• Garvan Medical Research Institute
• The George Institute for Global Health
• Hunter Medical Research Institute
• Ingham Institute for Applied Medical Research
• Neuroscience Research Australia
• Victor Chang Cardiac Research Institute
• Westmead Institute for Medical Research
• Woolcock Institute of Medical Research

What your application needs to include

You can download the full guidelines:

Application checklist

All applications must be submitted using the application kit available on the NSW Health and Medical Research website .

Valid applications must include:

• a completed Standard Application Form, with all supporting documentation included as separate, clearly labelled files
• a completed Grant Income Spreadsheet
• a copy of the applicant organisation’s most recent audited financial statement
• a signed Letter of Declaration.

Completed applications should be sent to [email protected] by 5pm Wednesday 17th July. 

Incomplete applications and/or applications received after this time will not be considered. Questions about the application process may be directed to the Office for Health and Medical Research at [email protected] .

Address the eligibility criteria

To receive funding from the MRSP, organisations must demonstrate that they meet ALL eligibility criteria.

• Located in NSW   The applicant organisation must be located in NSW.  
• Health and medical research is the primary  purpose of the organisation  Conducting health and medical research must be the primary purpose of the organisation. This does not exclude organisations that carry out other activities such as teaching and consultancy that are secondary to the research function. It does, however, exclude organisations for which research is a subsidiary function, for example, pharmaceutical companies whose primary purpose is to manufacture and sell pharmaceuticals. Evidence of the applicant’s purpose may include its mission statement and annual reports.  
• legal recognition of the organisation as a discrete operational entity
• an independent board or equivalent body that is not legally controlled by a university, local health district, specialty network, and/or a public or private health care facility
• organisational mechanisms to determine its own research direction and strategy, including a director with clear responsibilities regarding the organisation’s research direction and activities
• identifiable infrastructure and overall organisational budgets, and control over how funds are spent, including externally audited financial statements
• an intellectual property policy that is congruent with the National Principles of Intellectual Property Management for Publicly Funded Research (NHMRC, 2021).

Conducting high-quality research at sufficient scale  The applicant organisation must be conducting high-quality research at a sufficient scale, as demonstrated by an average annual income from eligible competitive grants of at least $3 million over the period 2021–2023. Nationally competitive health and medical research grants from the following sources are eligible for inclusion:

• Australian Research Council
• Cancer Australia
• Medical Research Future Fund
• National Health and Medical Research Council

Not all grants from these sources are eligible for inclusion. A grant is eligible only if it meets all the following criteria:

• Funds are provided on a nationally competitive basis.
• Funds are awarded for health and medical research.
• The scheme is advertised nationally and available to all Australian research organisations.
• The scheme has a well-defined mechanism for competition and selection by a qualified panel.

Additionally, the applicant institute must be responsible for the provision of infrastructure support for any research project claimed as eligible income. Grant recipients must report and be accountable to the applicant institute’s director (or equivalent). Where a researcher’s salary is paid by another organisation, a formal workplace agreement between the application institute and the researcher must be in place.  The Ministry of Health’s decision on the eligibility of grants is final. 

• certify the accuracy of evidence provided to fulfil criteria 4 and 5
• agree to NSW Health exchanging information provided in the application with other NSW Government-funded research infrastructure programs.

MRSP funding is NOT available to:

• Affiliations of convenience – weakly affiliated research groups that represent themselves as a single entity solely for the purpose of meeting the eligibility criteria
• Organisations that facilitate research – research communities representing themselves as research organisations, hubs or consortia
• Controlled entities or units of other organisations – research groups that have, for example, a university or health service as their parent entity.

Selection process

Step 1: initial eligibility appraisal .

Following the closing date for applications, the Office for Health and Medical Research (OHMR) will make an appraisal as to whether each applicant has satisfied all eligibility criteria. OHMR may request further information from applicants to clarify or confirm material contained in the application.

Step 2: Independent review of applications 

An independent review panel will review OHMR’s initial appraisal. The panel will be chaired by the Executive Director, OHMR and include the Chief Financial Officer, NSW Health and three independent members, including one interstate member.

Step 3: Recommendation to Minister

The panel will make a recommendation to the Minister for Medical Research on which applicants should enter the program and the proposed funding allocation for Period 1.

Step 4: Successful applicants announced

Once the Minister has made a decision, all applicants will be informed in writing of the result. This decision is final; no further correspondence will be entered into.

Step 5: Funding agreements initiated

OHMR will make contact with successful applicants to establish funding agreements.

Start the application

For Program Guidelines, Application Kit, and submission details, visit the NSW Health and Medical Research website .

After the application is submitted

Successful applications will be decided by: the Minister for Health

Following the closing date for applications, the NSW Health will make an initial eligibility appraisal, followed by review by an independent panel. 

The panel will make a recommendation to the Minister for Health on which applicants should enter the program and the proposed funding allocation.

All applicants will be informed in writing of the outcome.

Support and contact

Email: [email protected]  

Masks Strongly Recommended but Not Required in Maryland, Starting Immediately

Due to the downward trend in respiratory viruses in Maryland, masking is no longer required but remains strongly recommended in Johns Hopkins Medicine clinical locations in Maryland. Read more .

• Vaccines  
• Masking Guidelines
• Visitor Guidelines  

Johns Hopkins Medicine Clinical Research

Message from the Vice Dean

Gail Daumit , Vice Dean for Clinical Investigation, has released her plans for the future of the Clinical Research program. Learn about updates and expansions in her open letter.

Funding Opportunities

Junior and midlevel faculty member grant accelerator program application deadlines: october, 1 2024; and february, 1 2025.

The Grant Accelerator Program will provide onetime grants of $5,000–$15,000 to provide Core Coins for junior and midlevel faculty members and help them overcome barriers to successful grant submissions. These small awards provide a way to rapidly fund data acquisition and analysis that investigators need as part of their grant applications. The funds may be spent at any of the Cores on iLabs for clinical or laboratory projects. In addition to the funding, Core staff will be available to help applicants design analyses and interpret data.

The Grant Accelerator application is quick and easy to complete, requiring only a few brief responses and a one-page NIH format specific aims page . The application is available .

Upcoming application deadlines are  Oct. 1 and Feb. 1 , and we expect to fund 20–35 projects each cycle. Decisions and funding will be provided within one month of each application deadline. 

Research & Funding: Weekly Notice of Limited Submission (Grant!) Opportunities

The Vice Provost for Research office coordinates all limited submission activities on behalf of the University, and makes every effort to provide a current list of open opportunities to faculty. Please see list  here .

Get e-mail alerts about funding opportunities at  [email protected] .

What's New?

Digital and community engaged approaches to support research recruitment symposium, september 11th & 12th.

Research faculty, staff and trainees invited to attend the upcoming symposium titled "Digital and Community Engaged Approaches to Support Research Recruitment," to be held September 11-12, 2024, in the Turner Auditorium.

This two-day in-person event will serve as an educational platform for research professionals nationwide to exchange successful tools, strategies, and insights. Our goal is to enhance sustainable methodologies that increase participation in clinical and translational research. The symposium will feature esteemed speakers from the CTSA consortium, NCATS, and the NIH, offering a dynamic agenda that promises to be both informative and transformative.

To register: Webpage and Registration , see REDCap link if you wish to use tuition remission.

Office of Faculty- Fall 2024 Grant Writing Sessions with Carisa M. Cooney, MPH, CCRP

Do you have a grant that needs to be written soon? Join us for Guidance and Strategies for Crafting Competitive Funding Proposals , a series of six sessions, via Zoom, addressing the various components of grant applications. Sessions will include practice and critique of writing samples; provision of grant template components; and Q & A. Participants are strongly encouraged to attend all sessions, if possible. Seating is limited. Faculty members will be added to a waitlist once sessions are full.

All sessions are 9:00 AM - 4:00 PM, In-Person:

Fall 2024 Sessions

• Introductions & Grant-Writing Overview , Mon., 9
• Specific Aims Page , Mon., 23
• Research Strategy & Contributory Tables/Figures , Mon., 7
• Identifying Funding Mechanisms, Funds Available, & Proposal Components , Mon., Oct. 21
• Budget & Budget Justification , Mon., Nov. 4
• Supporting Documents (Biosketches, Other Support, Facilities, Data Sharing Plans, Letters of Support) , Mon., Nov. 18

Office of Faculty- Fall 2024 Scholarly Writing Sessions with Sarah Poynton, PhD and Rachel Walden, MS

Improve the chances that your manuscripts will be accepted and read. Scholarly writing is rarely taught; many faculty simply learn by doing it, with uneven results. These four sessions provide inspiring guidance on how to convey the importance of your study to reviewers and journal readers. Designed for native and non-native English speakers, the instructors identify the essentials of effective scholarly writing, highlight their application to different parts of a manuscript, and help you become a more powerful and efficient author. Seating is limited. Faculty members will be added to a waitlist once sessions are full.

All sessions are 9:00 AM - 4:00 PM, via Zoom:

• Scholarly Writing: A Suite of Four Sessions of Essential Guidance - Part 1 Fundamentals of Excellent Writing , Fri., Oct., 4
• Scholarly Writing: A Suite of Four Sessions of Essential Guidance - Part 2 Effective Titles and Abstracts , Fri., Oct., 18
• Scholarly Writing: A Suite of Four Sessions of Essential Guidance - Part 3 Powerful Introduction and Clear Methods , Fri., Oct., 25
• Scholarly Writing: A Suite of Four Sessions of Essential Guidance - Part 4 Compelling Results and Discussion , Fri., Nov 1

Office of Faculty- November 14th/15th Manuscript Writing Retreat with Sarah Poynton, PhD and Rachel Walden, MS

Prioritize two days of dedicated and supported writing time to progress a manuscript . In this two-day writing retreat, we offer you protected writing time, along with instruction and class critique, and the opportunity to work individually with a professional editor who will provide detailed feedback on your manuscript. Designed for faculty who have a manuscript in progress, the retreat provides many tools for enhancing the quality of your manuscript and accelerating its completion. Seating is limited. Faculty members will be added to a waitlist once sessions are full.

• Manuscript Writing Retreat, , Nov 14 - Fri., Nov 15 (9:00 AM - 4:00 PM, In-Person)

FREE editorial support for your grant proposals and manuscripts by the Research Development Team (RDT)

The Johns Hopkins Editorial Assistance Services Initiative (EASI) offers editorial support for grant proposals  and  journal articles at no charge to faculty. Details of services by the Research and Development Team can be found here: EASI

Updated Facilities and Administration Rate for Off-Campus Commercial Sponsored Research effective July 1, 2024

Due to increased investment in administrative infrastructure to support SOM-sponsored research, the off-campus rate for new commercial sponsored research awards will increase to 39 % from the current 34%, effective July 1, 2024. 

The on-campus rate of 72% remains unchanged.

The new off-campus rate applies to all new proposals for commercial sponsored research submitted on or after July 1, 2024. Existing awards will continue under the rate in effect as of the date of their original submission, as will any pending proposals submitted before July 1, 2024.

The Office of Federal Strategy Resources

The Office of Federal Strategy has developed the following resources to help faculty navigate through preparing for Congressional testimony, submitting effective comments to federal agencies, and best practices for moderating discussions with elected or appointed officials.

Tips for preparing Congressional testimony

Tips for submitting effective comments

Guide for moderators or facilitators

Lobbying FAQ  

Data Trust Resources

Data Trust office hours: Third Thursday of the month 8:30-9:30am via the Office Hours MS Teams channel . You can also find the library of recorded sessions .

The Research Data Subcouncil has several resources to guide study teams and answer questions about the Data Trust review process, the Risk Tiers Calculator, and access to and sharing of JHM data.

The Data Trust oversees the use and disclosure of JHM patient and plan member data stored in clinical enterprise systems. Visit the Data Trust site to learn more about data governance and best practices for JHM data.

Institutional Review Board Assistance

April 1, 2024 – update to clinical research hospital billing charges.

For those involved in clinical research hospital billing, please note that hospital billing statements generated after April 1, 2024 Hospital Billing (HB) charges from Johns Hopkins Health System facilities in Maryland will be discounted to 29.6% of the facility charge master for Government/Not for Profit organizations and to 44.4% for Pharmaceutical/For Profit sponsors. This is an increase from the previous research discount. Hospital Billing charges from Sibley Memorial Hospital and All Children’s Hospital will have an additional discount applied to maintain consistency across the Johns Hopkins Health System. See letter  for more information.

For any questions, please contact the Clinical Research Support Services (CRSS) team at [email protected] .

CCDA adjunct costs for 2024

Effective fiscal year 2024, we will be implementing the following fee structure for participating in the CCDA adjunct program. See letter  for more information.

• Annual support fee: $5,000 per CCDA adjunct and $4,000 per registry data manager. CCDA adjuncts have access to pull data from various institutional data sources and thus typically require more CCDA staff support; registry data managers are limited to the data in their provisioned registry and need less support.
• One-time onboarding fee: $5,000 for new CCDA adjuncts and registry data managers. This fee covers interviewing candidates proposed by the sponsoring department, initial training, mentoring, and review. This fee is in addition to the annual support fee.

Updates to the Human Subjects Research Compliance Training Registration Process

New ways to communicate with the office of human subjects research (ohsr) and the institutional review board (irb).

The OHSR and IRB staff have two new ways to communicate with you:

• Microsoft Teams. On the Contact page, you can find contact information for staff members, including new Microsoft Teams phone numbers, email addresses and newly added links to chat with a staff member.

Request a Consult . If you want a comprehensive discussion about, e.g., protocol planning assistance, please request a consult , and the OHSR staff will connect you with an appropriate team member.

The IRB and Data Trust streamline data sharing across JHU

Data protection attestation has been integrated into eIRB and public health institutional review system tracking (PHIRST) to enable sharing of limited data sets among Johns Hopkins University (JHU) researchers. This change eliminates the need for a data use agreement for most transfers of a limited data set to JHU collaborators. New guidance is now available to help JHU researchers?navigate the process?and requirements?for requesting use of Johns Hopkins Medicine (JHM) data.

• Review information on sharing Johns Hopkins Medicine data on the JHM Data Trust intranet site.?
• For more information on data protection attestation, see frequently asked questions.

Interested in research using artificial intelligence?

Johns hopkins office of clinical trials.

The new Johns Hopkins Office of Clinical Trials (JH-OCT) will help Johns Hopkins clinical investigators and research teams to push the boundaries of discovery with unparalleled support to develop, initiate and conduct clinical trials within the framework of human research participant protection and regulatory compliance. The JH-OCT brings together three groups in the school of medicine Office of Research Administration that provide essential services to efficiently move clinical trials contracts and budgets forward:  clinical research contracting, clinical research support services and clinical research billing compliance . JH-OCT is the gateway for clinical investigators to find the tools, resources and support required to advance discovery and clinical care in our community and beyond.

Mark Sulkowski, MD Professor of Medicine Senior Associate Dean for Clinical Trials

Institutional Review Board (IRB)

Institute for clinical and translational research, office of research administration (ora, for noncommercial funders), ora clinical research contracting (for commercial sponsors), clinical research support services (for planning and budgeting of clinical trials), investigational drug service, clinical research billing compliance, research it.

• Skip to content

Search UMMC

Mobile Navigation

• ⌂ UMMC Home
• Academic Affairs
• For Prospective Students
• For Students
• For Residents and Fellows
• For Faculty
• School of Dentistry
• School of Graduate Studies
• School of Health Related Professions
• School of Medicine
• School of Nursing
• School of Population Health
• UMMC Online
• Faculty Directory
• Health Care Home
• All UMMC Services
• Children's of Mississippi
• Find a Doctor
• Find a Location
• UMMC Pricing
• Patient and Visitor Information
• Referring Physicians
• Research Home
• Centers and Institutes
• Participate in Clinical Trials
• A-Z Site Index
• Accreditations
• Jobs at UMMC
• Mission and Vision
• Appointments
• Office of Research and Sponsored Programs / Pre-Award
• Office of Research and Sponsored Programs / Post-Award
• Human Research Office (IRB)
• Office of Animal Welfare (IACUC)
• Office of Clinical Trials
• Institutional Biosafety Committee
• Intellectual Property and Commercialization Office
• Radiation Safety Office
• For more information
• Institutes Overview
• Cancer Center and Research Institute
• Myrlie Evers-Williams Institute for the Elimination of Health Disparities
• UMMC Neuro Institute
• Centers Overview
• Basic and Advanced Resuscitation Training Center
• Cardiovascular-Renal Research Center
• Center for the Advancement of Youth
• Center for Bioethics and Medical Humanities
• Center for Comparative Research
• Center for Informatics and Analytics
• Center for Innovation and Discovery in Addictions
• Center for Integrative Health
• Center for Tobacco Treatment, Education and Research (ACT)
• Children's of Mississippi Center for Cancer and Blood Disorders
• Children's Safe Center
• Jabaley-Songcharoen Center for Hand, Upper Extremity and Nerve Surgery
• Memory Impairment and Neurodegenerative Dementia (MIND Center)
• Mississippi Center for Heart Research (MCHR)
• Mississippi Center for Obesity Research (MCOR)
• Mississippi Center of Excellence in Perinatal Research
• Mississippi Clinical Research and Trials Center
• Simulation and Interprofessional Education Center
• UMMC Biobank
• UMMC Center for Telehealth
• Women's Health Research Center
• Clinical Centers Overview
• Center for Maternal and Fetal Care
• Center for Neuromuscular Disorders
• Center for Sialendoscopy and Salivary Gland Disorders
• Children's Heart Center
• Clinical Epilepsy Center
• Esophageal Health and Reflux Center
• Face and Skin Center
• Gearhart Clinical Skills Center
• Mississippi Burn Center
• Mississippi Center for Emergency Services
• Morris Center for Cleft and Craniofacial Research and Innovation
• University Heart Center
• Voice and Swallowing Center
• External Designation Center Overview
• Cardiorenal and Metabolic Diseases Research Center
• Center for Telehealth
• Comprehensive Stroke Center
• Cystic Fibrosis Care Center (Adult)
• Cystic Fibrosis Center (Pediatric)
• Mississippi AIDS Education Training Center
• Mississippi Center for Clinical and Translational Research
• Mississippi Centre for Evidence-Based Practice: A Joanna Briggs Institute Centre of Excellence
• Mississippi Poison Control Center
• Molecular Center of Health and Disease
• Biochemical Assay Core/Analytical and Assay Core
• Analytical Ultracentrifuge Facility
• Biomedical Materials Science Labs
• Histology Core
• Mass Spectrometry Core
• Molecular and Genomics Core
• Transgenic Core
• Research Resources
• Funding Opportunities
• Research Fast Facts
• Patient Cohort Explorer
• Research Visitors
• Rowland Medical Library
• Workshops and Training
• CREW Program
• Find a Clinical Trial
• How to Participate in Clinical Trials and Research
• Mississippi Rare Disease Registry
• Dentistry Student Research
• Graduate Studies - Summer Undergraduate Research Experience (SURE)
• Medical Student Research Program (MSRP)
• Pediatric Research and Clinical Education Program (PReCEP)
• Psychiatry Medical Student and Resident Research
• Student Training
• For Researchers

Intramural Research Support Program

• UMMC Research Home
• Research Offices
• Core Facilities
• Funding Opportunities Home
• Intramural Research Support Program Home
• Educational and Research Visitor
• Faculty/Staff Training Home
• Research with Animal Subjects
• Research with Human Participants
• Working with Potentially Infectious Material
• Working with Radiation/Radioactive Materials or Lasers
• Become a Clinical Trials Participant
• Benefits of Being a Clinical Trials Participant
• Frequently Asked Questions
• Research Study Resources for Participants
• Studies Available for Enrollment

The IRSP program was created to strengthen the biomedical research environment at the University of Mississippi Medical Center through the use of flexible funds that enable faculty to respond quickly and effectively to emerging opportunities and unpredictable circumstances that develop during the course of active research programs. The highest priority for awards will be for those projects that are most competitive for future extramural funding. 

The IRSP provides support in the form of 12-month awards of $30,000 or less to members of the UMMC faculty to pursue a research project. Applications are accepted in three categories: Basic Science, Clinical, and Population Health. Applications for targeted announcements (i.e., Cancer Research) may also be accepted each year. Grant support can be used for initial research support for new and newly-relocated faculty, pilot studies, and bridge funding.

FY2024 Application Dates

*Specific Aims/Mentors: Investigators who have not been previously funded by external sources are required to send a Specific Aims (1 page) and names (2-3) of your grant mentoring team to Cari Fowler and Meagan Follett at least one month prior to the IRSP deadline. Failure to comply with this guideline may result in the application not being reviewed by the study section. Investigators who need the names of potential mentors should contact Dr. Caroline Compretta . 

More information and the following can be found on the Research/IRSP intranet:

• Application
• IRSP application guide/instructions

Non-competing IRSP funding

The Non-Competing IRSP Funding Program was created in 2016 to ensure timely resources are available to strengthen resubmissions for investigators who receive highly-scored but unfunded extramural applications.

An application cannot be submitted to the NC-IRSP and be submitted/under review for the IRSP simultaneously.

More information and the following can be found on the  Research/IRSP intranet :

• NC-IRSP application guide/instructions

• Department of Health and Human Services
• National Institutes of Health

Medical Research Scholars Program

Press Release : NIH Announces 2023-2024 Medical Research Scholars Program Class

The Medical Research Scholars Program is a year long research immersion program for future clinician-scientists that advances health by inspiring careers in biomedical research. By engaging students in basic, clinical, or translational research investigations, offering a curriculum rich in didactics and professional development, and featuring a robust mentorship and advising program, MRSP prepares its Scholars to become tomorrow's leaders in medicine and biomedical research.

Eligibility

The 10.5-12 month program is designed for students who are U.S. citizens or permanent residents, have a strong interest in conducting basic, translational, clinical or epidemiological research and are currently enrolled in their 2nd, 3rd, or 4th year at an accredited medical, dental, or veterinary program .

Dental and veterinary students: due to the integrated nature of the third and fourth (clinical) years, participation in the MRSP is recommended after you have completed your second or fourth year in school.

There are designated start dates in late June and July. No start dates are available prior to late June. Participants are expected to meet the required 10.5-12 month timeframe based on the established start dates of the program and leave no earlier than mid-May.

Acknowledgement Statement

The National Institutes of Health (NIH) Medical Research Scholars Program is a public-private partnership supported jointly by the NIH and contributions to the Foundation for NIH, alumni of student research programs, and other individual supporters via contributions to the Foundation for the National Institutes of Health.

NOTE: PDF documents require the free Adobe Reader .

This page last updated on 05/21/2024

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at https://www.cc.nih.gov/disclaimers.html

Medical Research

Scientists and physicians in academic medicine conduct groundbreaking biomedical research that improves our knowledge of human health and promotes the development of treatments from bench to bedside to community.

Through policy and advocacy initiatives, data and research projects, professional learning and networking opportunities, and the development of tools and resources, the AAMC supports the entire spectrum of medical research from basic discovery and translational science to clinical and population health research, research policies and regulations that promote robust and ethical science and minimize administrative burden and a diverse biomedical research workforce and an inclusive and equitable research environment across all career stages.

On this page:

Science policy updates .

AAMC updates on federal science policy and regulatory topics impacting institutions and researchers can be found below. 

The AAMC submitted a letter to FDA and HHS on draft guidance.

• May 3, 2024

AAMC submitted comments to the Department of Justice regarding access to bulk sensitive personal data by countries of concern.

• April 26, 2024

AAMC submitted comments to the National Institutes of Health (NIH) on the updated NIH Strategic Plan for Data Science, 2023-2028

• March 15, 2024

For more on the latest legislative and regulatory activities affecting academic medicine, check out Washington Highlights . For the latest news, current trends, and ongoing conversations about the most important topics in academic medicine, visit AAMCNews .

Meet our New Chief Scientific Officer

As chief scientific officer, Elena Fuentes-Afflick, MD, MPH, leads AAMC programs that support medical research and the training of physician-scientists and researchers in academic medicine. In this role, she provides leadership and vision for addressing research and science policy and other related critical issues facing academic medicine, medical schools, teaching health systems, and teaching hospitals. Learn more about Dr. Fuentes-Afflick .

Connect with Colleagues

The AAMC convenes several affinity groups focused on connecting individuals who work in biomedical research or support researchers at their institution. Affinity groups include councils, professional development groups, and other organizations that provide individuals at member institutions access to professional growth, leadership development, networking, and collaboration opportunities.  

Find information about how to join each group on the pages below. 

CFAS represents the collective interests of medical school faculty and academic societies on a range of cross-cutting issues.

GRAND convenes research leaders in discussion of issues critical to the research enterprise and linking research advancements with improvements to health.

GREAT provides a forum for discussion of the research training enterprise with leadership of biomedical graduate, postdoctoral, and MD-PhD programs.

FOCI provides a national forum for leadership who oversee and manage conflict of interest related to research, medical education, and clinical decision-making.

The GDI unites expertise, experience, and innovation to guide the advancement of diversity, equity, and inclusion throughout medicine and biomedical sciences.

The research subgroup of COF promotes compliance and ethical conduct in academic medicine with a specific focus on research and laboratory issues.

Attend an Event

The AAMC is committed to providing professional learning opportunities for biomedical researchers in every stage of their career. Find information about the AAMC’s webinars, meetings, and more below.

Related AAMC Initiatives

The AAMC engages in other work that may be of interest to researchers and scientists:

The Center sparks community-centered, multi-sector research, collaboration, and action to make the case for policies and practices that ensure all communities have an equal opportunity to thrive.

An optimal research environment that drives impactful biomedical discovery is supportive, diverse, equitable, and inclusive.

• U.S. Department of Health & Human Services

• Virtual Tour
• Staff Directory
• En Español

You are here

Medical research initiatives, sars-cov-2-3d-illustration-square.jpg.

NIH’s COVID-19 Strategic Response

NIH’s response plan includes five strategic priorities to guide COVID-19 programs and research.

GettyImages-1152335789.jpg

Advanced Research Projects Agency for Health (ARPA-H)

A research funding agency that supports transformative biomedical and health breakthroughs to provide health solutions for all.

activ-hex-collage.png

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)

Prioritizing and speeding development of the most promising treatments and vaccines.

radx-circle-collage.png

Rapid Acceleration of Diagnostics (RADx)

An initiative to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing.

20210610-covid-statement.jpg

A new research initiative to understand, prevent, and treat the long-term effects of COVID-19.

improve-initiative-pregnant-woman-teaser.jpg

IMPROVE Initiative

Learn more about NIH research to address the rising U.S. rates of pregnancy-related deaths.

21st-century-cures-thumbnail.jpg

21st Century Cures Act

Providing NIH with critical tools to further advance biomedical research, promote innovation and speed development of new therapies.

cancer-moonshot-thumbnail.jpg

Cancer Moonshot SM

Cancer prevention and detection, while making more therapies available to more patients.

brain-connectome.jpg

The BRAIN Initiative

Learn about an audacious initiative aimed at revolutionizing our understanding of the human brain.

mecfs-tagcloud.png

Advancing ME/CFS Research

Learn about shared areas of interest and challenges to advance ME/CFS research.

precision-medicine-silhouettes.jpg

All of Us SM Research Program

Learn about disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle.

preschool-children-smiling.jpg

Environmental influences on Child Health Outcomes (ECHO) Program

Learn about new research to understand environmental influences on child health.

AMP-Tag-Cloud.png

Accelerating Medicines Partnership ® (AMP ® )

A bold venture to help identify new treatments and cures for diseases.

female-researcher-using-microscope-square.jpg

Rigor and Reproducibility

Information about the efforts underway by NIH to enhance rigor and reproducibility in scientific research.

technology-data-abstract.jpg

Data Science at NIH

Harnessing the potential of the computational and quantitative sciences to elevate the impact and efficiency of biomedical research.

fingers-holding-puzzle-piece.jpg

Find out about the “Enhancing the Diversity of the NIH-funded Workforce” Program.

heal-initiative-father-baby.jpg

NIH HEAL Initiative

Trans-agency effort to speed scientific solutions to stem the national opioid crisis.

DS_plan.jpg

INCLUDE Project

Agency-wide initiative on the critical health needs of individuals with Down syndrome.

women-biomedical-careers.jpg

Women in Biomedical Careers

Learn how NIH is maximizing the potential of women scientists and engineers.

nih-common-fund.jpg

NIH Common Fund

Learn how NIH is accelerating discovery by supporting cross-cutting, trans-NIH programs.

nih-blueprint-neuroscience.jpg

Blueprint for Neuroscience Research

Learn how NIH is enhancing collaboration in support of research on the nervous system.

spotlight-2.jpg

Sound Health: An NIH-Kennedy Center Partnership

Music can get you moving, lift your mood, and even help you recall a memory, but can it improve your health?

climate-change-boat-flooded-street.jpg

Climate Change and Health Initiative

Research to reduce health threats from climate change.

Connect with Us

• More Social Media from NIH

Funding Areas

Medical research.

Doris Duke was a significant supporter of medical research, making contributions to hospitals and research centers throughout her life. In her will, which guides our focus areas, she expressed her interest in advancing “medical research designed to effectuate cures of major diseases.”

The Doris Duke Foundation strives to advance the prevention, diagnosis and treatment of diseases by strengthening and supporting clinical research.

Why It's Important

Clinical research has the potential to enhance human health and reduce the burdens of illness for many. Clinical research spans everything from the study of diseases at the molecular level in order to identify cures and vaccines to insights about how to improve the delivery of medical therapies, clinical care and population-level health. While the full spectrum of clinical research plays a critical role in ensuring a healthy society, the vast majority of public and private funding for biomedicine tends to emphasize fundamental research on the mechanisms of disease. For this reason, the Doris Duke Foundation focuses on supporting a wide variety of pathways to medical innovation—especially those that receive relatively less attention. We believe scientific excellence through diverse forms of clinical research can help deliver valuable, transformative and measurable health benefits to all.

What We Support

Through its Medical Research Program, the foundation supports timely initiatives that accelerate the translation of biomedical discoveries, technology and medical insight into clinical applications that equitably improve human health. In particular, we focus on incentivizing early-career creativity in clinical research as well as efforts aimed at building a more equitable medical research enterprise.

Grantmaking Process

The Doris Duke Foundation makes timely strategic investments in support of ideas that advance our mission. We invest in both research and efforts aimed at influencing the culture, practice and policy of clinical research. When appropriate, the foundation issues a limited or open request for applications (RFA). Applications received in response to an RFA typically undergo rigorous internal review as well as external peer review by independent experts. While these grants often fund work conducted by individuals, the direct grant recipient is the associated institution.

Seeking a grant?

View our latest funding opportunities and open competitions

News & Insights

Stay close to the conversation

Thank you for your submission..

We have added you to our mailing list.

Check your inbox for a confirmation email. You may update your settings as well as review your preferred contact address at any time.

• Applied Research
• Basic Research

Clinical Research

Labs & service centers.

• Research Resources

Clinical Research at Jefferson consists of the Sidney Kimmel Medical College, College of Life Sciences, College of Health Professions, College of Pharmacy, College of Nursing, College of Population Health, and associated support services. Our mission is to serve society through enhancement of health and well-being. We pursue that mission through medical research, health services, and education of physicians, health professionals and scientists in related disciplines.

For Patients

Medical breakthroughs wouldn’t be possible without the patients who volunteer to participate in clinical trials. We invite you to explore the resources on this page to learn more about what it means to participate in a clinical trial, how to find a study to volunteer for, and to learn more about the research happening at Jefferson. 

Go straight to our clinical trial finder.

Clinical Trials

Jefferson conducts cutting edge research to advance science and medical treatments globally. By participating in clinical research you are investing in yourself, your community and the future of research. It is our partnerships with our volunteers that help create breakthroughs and further medical knowledge and treatments

For Research Personnel

The Jefferson Clinical Research Institute (JCRI) offers a variety of services designed to promote the successful development, implementation, and management of clinical research at Thomas Jefferson University.

Click through to access your resources.

Sponsors & Partners

Thomas Jefferson University and Thomas Jefferson Hospital values our ongoing partnerships with sponsors, CROs, and other academic and medical institutions. 

We are always open to new collaborations and believe that together we can leverage our resources to reach common goals and outcomes more efficiently than we could on our own. 

Click through to learn more about partnering with us. 

Jefferson houses a variety of shared resources for its faculty and staff. These assets include in-house statisticians, a bio-printing laboratory, several clinical research support offices, our center for urban health, and a cancer genomics and bioinformatics core. 

Funding Opportunities

Jefferson emerging medical scholars program (jems) junior faculty award.

The Jefferson Emerging Medical Scholars Program (JEMS) Junior Faculty Award is an initiative between the Office of the Provost and the Jefferson Clinical Research Institute (JCRI) to support junior faculty in developing their careers in clinical research.

Provost’s Pilot Clinical Research Award

The Provost’s Pilot Clinical Research Award is an initiative of the Jefferson Committee on Research (JCOR), awarded through the Office of the Provost. Specific goals of the Provost’s Pilot Clinical Research Award are to foster collaborative research and team science, and to develop clinical research topics that have been minimally explored at Jefferson.

Pediatric Award for Clinical Research (PACR)

The Thomas Jefferson University & Nemours Children’s Health Pediatric Award for Clinical Research is an initiative of the Jefferson and Nemours Children’s Health Pediatric Department to promote interdepartmental research.

Main navigation

• For Researchers
• Research Resources

Clinical Research at HDFCCC

Clinical research at the HDFCCC is supported by four units:

Clinical Research Support Office (CRSO)

Clinical Research Programs

• Provides central oversight and a core of personnel with expertise in all types of clinical trials management
• Supports investigators in the conduct of cancer-related therapeutic or nontherapeutic clinical trials

Regulatory Affairs

• Provides protocol development and editing, consent form development, full regulatory compliance, and IND/IDE filing and maintenance
• Prepare and submit Institutional Review Board (IRB) applications and ancillary safety committees (i.e. Radiation Safety).

Contact information:

    CRSO Medical Director     Nicholas Butowski, MD |  [email protected]

    CRSO Director     Andrea Skafel, MSc, CCRP |  [email protected]

Protocol Review and Monitoring System (PRMS)

Site Committees

• Disease or modality specific scientific and feasibility review
• Prioritization of each new concept and protocol as it relates to the patient population and research focus of each site committee

Site Committee Chairs and Administrators

Protocol Review and Monitoring Committee (PRMC)

• HDFCCC-wide scientific and feasibility review
• Monitors for adequate accrual and ongoing scientific relevance, and closes studies that do not accrue or lose scientific relevance.

PRMC Meeting Schedule

PRMC roster

PRMC Chair Matthew Gubens, MD, MS |  [email protected]

PRMS Administrator Jenna Weight |  [email protected]

Data and Safety Monitoring Committee (DSMC)

Monitoring Office

• Monitoring and Auditing of interventional IITs and NCI cooperative group trials
• Preparation of study teams for external audits and inspections

Education and Training Office  (MyAccess login required)

• Onboarding and continual education of clinical research staff
• CRC Onboarding Series
• Regulatory Training Series
• Investigator Training
• Continual Education
• SoCRA Exam Preparation

NCI Approved DSMP  (version 18Mar2024)

DSMP Templates for Protocols   (version 15Aug2024)

DSMP Approval Letter   (version 15April2024)

DSMC Roster  (v 7 Aug 2024)

DSMC 2024 Meeting Calendar

Contact Information:

DSMC Chair Katie Kelley, MD |  [email protected]

DSMC Director John F. McAdams, MS, CCRP |  [email protected]

Clinical Research Network Office (CRNO)

Regional Affiliate Partnerships

• Develop, streamline and improve oncology clinical research opportunities at partner sites around the bay area

National Clinical Trials Network (NCTN)

• Manage the  UCSF NCTN program and all associated affiliate sites

CRNO Medical Director Mary Feng, MD |   [email protected]

CRNO Director Arla Yost, MSc, CCRP  |  [email protected]

These units are guided by the Cancer Center Clinical Research Oversight Committee (CCCROC).

Together the units provide a centralized mechanism to support cancer clinical research and assist HDFCCC members with conducting clinical studies in compliance with all federal, state and local regulatory requirements.

Additional Resources

• HDFCCC Clinical Research Policies
• UCSF Clinical Research Resource HUB

This unit is supported by a National Cancer Institute Cancer Center Support Grant (P30CA082103). Any publications related to work done by this core should reference grant number P30CA082103 and must include a PMCID as required by the NIH. View instructions on how to acknowledge funding sources and how to obtain a PMCID .

For inquiries about Cancer Center Shared Resources, please email Benjamin Braun, MD, PhD .

Regulatory Affairs Training Program

This program provides an overview of premarket regulatory work related to drugs, biologics, and medical devices, covering the following topics:

• Drug Development and FDA Meetings
• Applicability of FDA Drug Regulations to Clinical Studies
• IND Content, Format, Review and Maintenance
• Medical Device Development and FDA Meetings
• Applicability of FDA Device Regulations to Clinical Studies
• IDE Preparation, Submission, and Maintenance 

Enrollment to the program occurs on a rolling calendar basis and the program is offered remotely via Zoom. After registering for this program, participants will be contacted prior to the start of that program and so we kindly ask that you limit inquiries regarding session availability.  

Interested in participating?   

If you are interested in participating in the upcoming Fall 2024 program and would like to be notified when the registration form is available, please complete the  ORAQ Regulatory Affairs Training Program Interest Form .  The sessions will occur on Fridays at 12:00 PM EST October 11th-Novmeber 15th 2024. The registration form will be sent out via email the week of September 9th to all individuals who have completed the interest form. 

Questions about the program? 

Please read our FAQs about the program below. If you have a question that is not addressed, please email  [email protected] .

Popular Services

• Patient & Visitor Guide

Committed to improving health and wellness in our Ohio communities.

Health equity, healthy community, classes and events, the world is changing. medicine is changing. we're leading the way., featured initiatives, helpful resources.

• Refer a Patient

NIH awards Ohio State $4.3 million grant to build clinical and translational scientist pipeline

August 19, 2024

COLUMBUS, Ohio – The National Institutes of Health has awarded The Ohio State University a $4.38 million grant to support newly trained clinician-scientists for careers in medical research. 

The 5-year award will fund the Clinical and Translational Science Institute K12 program, a mentored research and education program for early career clinical and translational scientists.

“This career development grant offers junior faculty vital education, mentorship and resources to help them achieve their career and research goals,” said K. Luan Phan, MD , principal investigator, clinical professor and chair of the Department of Psychiatry and Behavioral Health at The Ohio State University College of Medicine and chief of Psychiatry Services at The Ohio State University Wexner Medical Center . “Clinical and translational scientists are an essential part of health care for their combined ability to identify and conduct research that address gaps in patient care.”

The Clinical and Translational Science Institute K12 program provides research funding, salary support and training in clinical and translational science. The K12 program creates opportunity for up-and-coming researchers to develop under the mentorship of experienced researchers. 

In 2024, four faculty members will receive the K12 award. It’s open to early-career faculty engaged in clinical or translational research.

New name for translational science center

The Ohio State University Center for Clinical and Translational Science is now the Clinical and Translational Science Institute. The updated name better aligns with the institute’s mission to advance discovery and improve health for all. 

“For the past two decades, the institute has been an impactful resource to the scientific and research community at Ohio State,” said Julie Johnson, PharmD , Clinical and Translational Science Institute director, associate dean for clinical and translational research at the Ohio State College of Medicine and associate vice president of research at Ohio State. “Our aim moving forward is to more fully serve the entire clinical and translational research community on campus and at Nationwide Children’s Hospital, and to facilitate and streamline research discoveries that improve health for all.”

Research reported in this press release was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UM1TR004548.

Media Contact: Serena Smith, Wexner Medical Center Media Relations, [email protected]

Subscribe. Get just the right amount of health and wellness in your inbox.

Support for Conducting Clinical Research: Investigator-Initiated Studies (IIS) Program at Stryker Medical

Physician and nurse investigators who want to conduct research using our products are invited to request support through our Investigator-Initiated Studies (IIS) Program. Click on the following links for products within the Stryker Acute Care ,  Emergency Care Transport , and Sage product portfolios. 

The IIS Program is open to qualified clinical investigators who are interested in independently planning, designing, sponsoring, executing, and publishing their own research. Support for IIS research may provide funding and/or product support for original clinical research in therapeutic areas that are of mutual interest.

Current areas of research interest include:

• Pressure injury prevention
• Surgical site infection (SSI) prevention
• Comprehensive oral care
• Early patient mobility
• Safe patient handling/injury prevention
• Hospital-Acquired Infections (HAIs)
• Urine management
• Targeted temperature management

Proposals may be initiated by submitting an Investigator-Initiated Studies Request for Support Form (IISRSF), located below. After the IISRSF is received, you may be contacted by a member of Clinical Affairs to collect additional information or answer questions. Your proposal will then undergo a formal internal review, and a member of Clinical Affairs will contact you to share our support decision.

For further information regarding our process, please contact us:  [email protected] .

• Campus Life
• Administration
• Clinical Services
• Educations & Health Care Partners
• Facts & Figures
• History & Mission
• Strategic Planning
• University Leadership

Continuing Education

• Degrees & Certificates
• Academic Departments
• Interprofessional Education
• Pre-Med & Pre-Pharmacy Programs
• Become a Physician
• Become a Pharmacist
• Become a Dentist
• Pursue Graduate Studies
• Tuition & Fees
• Financial Aid
• Apply to NEOMED
• Plan a Visit
• Admitted...Now What?
• Diabetes, Obesity & Metabolism
• Heart & Blood Vessel Disease
• Health Services Research
• Hearing Research
• Musculoskeletal Research
• Neurodegenerative Disease & Aging
• Facilities & Technology
• Research Administration
• Student Research
• The REDIzone®
• Tech Transfer
• Campus life
• Student Activities & Events
• Health & Wellness
• Housing & Dining
• Campus Safety

Clinical and Translational Research Institute

Overview of the institute in about 70 words. Lorem ipsum dolor sit amet, consectetur adipisicing elit. Natus, optio, totam impedit doloremque voluptatum laboriosam qui perferendis vitae at repudiandae temporibus debitis id sit. Sequi asperiores cupiditate earum doloremque distinction. Ally bettzine coloform.

Statistical consulting for NEOMED faculty and Graduate Students

Error vel, quaerat illo praesentium accusamus quis aut ducimus et blanditiis nam eveniet pariatur molestias, saepe qui aperiam natus:

• Repudiandae dolorum facilis vero at
• Commodi dolorem quidem, optio ipsam magni.

Recusandae optio aliquam qui libero nemo numquam repudiandae facilis aperiam dicta, quo obcaecati? Nobis, cum quos voluptates maxime itaque nam vero, debitis possimus recusandae sit officiis repellendus officia minus eveniet. Schedule an appointment .

Statistical consulting for external clients

Coming soon: Deserunt rerum consectetur voluptatum earum tenetur praesentium, qui eum provident perspiciatis vitae. Molestiae eveniet, quos, distinctio dolor quis aliquid recusandae culpa veniam iste, eligendi provident minima eos quas ipsum libero. Join our waitlist .

For all: Seminar series

Coming soon: Quibusdam magnam dolore placeat praesentium molestias ex, odit officia incidunt, optio aliquid porro consequuntur quas reiciendis harum in minus. Doloremque libero ullam aspernatur provident, ut illum eaque aliquam sint distinctio.

Schedule a consultation

The Clinical and Translational Research Institute (CTRI) offers two ways of obtaining high-quality statistical support:

• scheduling an appointment at our Statistical Collaboration Lab (Stat Lab), and
• visiting our Walk-In Lab.

Appointments for the Stat Lab are recommended for support relating to research proposals, study design, and more complicated statistical analyses.

The Walk-In Lab is recommended for basic one-off questions and guidance with data wrangling, data visualization and common statistical analyses.

Stat Lab scheduling

Initial one-hour consultation appointments are free of charge. Appointments are held in-person and are available by request. To book your appointment with CTRI faculty, please email [email protected] . Once you have scheduled an appointment, please complete the CTRI consulting intake form.

Intake form

Walk-In Lab schedule

The Walk-In Lab is a free-of-charge service. CTRI faculty are available for in-person, walk-in service every Tuesday and Thursday, 1-2 p.m., in Room F240 at the NEOMED campus. Please note hours are subject to change.

We ask that clients limit their visits to the Walk-In Lab to one per week.

We allow 30 minutes per client per visit or up to 60 minutes if no one is waiting. Please be patient if we are meeting with another client.

Philip Turk, Ph.D., M.S.

Dr. Philip Turk is a Professor in the Department of Family and Community Medicine and the Director of the Clinical and Translational Research Institute at Northeast Ohio Medical University.

Prior to this, he was a Professor and Chair in the Department of Data Science in the John D. Bower School of Population Health at the University of Mississippi Medical Center. Prior to this, he was an Associate Professor and Director of Biostatistics and Data Science at the Center for Outcomes Research and Evaluation at Atrium Health in Charlotte, North Carolina.

Turk earned his M.S. in Biology at Western Illinois University and his Ph.D. in Statistics at Montana State University. Before he joined Atrium Health, he had joint appointments as an Associate Professor of Statistics in the Department of Statistics and statistical consultant at the Graybill Statistical Laboratory at Colorado State University; and as an Assistant Professor of Statistics in the Department of Statistics and statistical consultant at the Davis College Experiment Station, West Virginia University. Early in his career, he worked at Abbott Labs supporting the development of medical diagnostics and devices from research to market launch.

Turk is the co-author of almost 60 referred publications. He has been part of research projects funded by more than 30 grants or other extramural funding and has been lead presenter or co-presenter of almost six dozen posters and talks. He is a member of the American Statistical Association, International Statistical Institute, and the R Epidemics Consortium. His primary areas of expertise are sampling, network analytics, Bayesian methods, statistical computing, and advanced modeling and forecasting, and teaching.

Jennifer Reneker, Ph.D., PT

Dr. Jennifer Reneker is a Professor in the Department of Family and Community Medicine and the Associate Director of the Clinical and Translational Research Institute at Northeast Ohio Medical University.

Dr. Reneker is an epidemiologist and innovator, focusing on physical therapy interventions. Prior to this, she was an Associate Professor in the Department of Population Health Sciences at the University of Mississippi Medical Center (UMMC); she also served as an Assistant Dean of Scholarly Innovation within the John D. Bower School of Population Health.

Since 2012, Dr. Reneker’s research efforts have been directed toward the advancement of evidence-based prevention and management strategies for mild traumatic brain injury.

In this area of inquiry, she has led and published numerous research studies. Through the Center of Excellence in Telehealth at UMMC, she was the principal investigator for a Health Services Resource Administration funded project using an innovative strategy in headset virtual reality to diagnose and treat injury in collegiate athletes.

This project was the third in a line of inquiry which sought to develop novel preventive training, diagnostic examination tests, and rehabilitative treatments using virtual reality to address concussion, both in-person and remotely through telehealth.

Dr. Reneker’s interest in innovative ways to diagnose and treat sensorimotor deficits after concussion and her pursuit of technological capacities has led to the pursuit of methods and system patents.

Sharad Shanbhag, Ph.D.

Dr. Sharad Shanbhag is a Research Associate Professor in the Department of Anatomy and Neurobiology at Northeast Ohio Medical University. His training is in systems neuroscience, specifically on the neural control of movement and auditory processing. His ongoing research uses neurophysiological, imaging, behavioral and analytical methods to explore how the amygdala coordinates emotional responses to social vocalizations.

Clinical and Translational Research Institute at NEOMED [email protected]

© 2024 Northeast Ohio Medical University 4209 St. Rt. 44, PO Box 95, Rootstown, Ohio 44272

ADA compliance | Consumer information | Title IX | Privacy statement

College of Medicine

College of Pharmacy

Graduate Studies

Bitonte College of Dentistry

Executive Education

Health Care

NEOMED Health Care

NEOMED Free Clinic

Creating Transformational Leaders

You are using an outdated browser. Please upgrade your browser to improve your experience.

• MRDC FAMILY

DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

Contact us | site map.

Transforming Health Care through Innovative and Impactful Research

• Funding Opportunities
• Program Funding Opportunities
• Arthritis Research Program

Program Funding Opportunities FY24 Arthritis Research Program (ATRP)

Synopsis of FY24 ATRP Award Mechanisms - (Adobe PDF) - provides a brief description and key elements of the award mechanism.

Quick Links:

• ATRP Home Page
• U.S. Department of Education Accredited Postsecondary Minority Institutions List
• Webinar Series

For further information, please send e-mail to:

CDMRP Webmaster - for download-related questions [email protected] - for program announcement-related questions

Last updated Monday, August 19, 2024

The University of Washington Department of Rehabilitation Medicine has been recognized for decades as an international leader in rehabilitation research. Our researchers and clinician-scientists from a diverse set of rehabilitation professions work collaboratively to perform innovative and impactful research covering a large breadth of patient populations and scientific methodologies. Research aimed at enhancing the health, function, and quality of life of the communities we serve is integral to our departmental mission.

Strategic Plan for Advancing Research

We recently developed a comprehensive strategic plan focused on conducting the highest quality and most impactful rehabilitation research. Advancing the key focus areas of this strategic plan will enable our department not only to enhance our research program, but also serve as a potential template to strengthen our clinical and teaching programs as well.

To ensure the strategic plan reflects the perspectives of the entire department, a group of faculty, staff, and trainee stakeholders from across departmental divisions were engaged throughout the strategic planning process. Through our process of discovery, we have learned not just about our many strengths, but areas where we need to build.

We envision a future with a diverse, collaborative, and innovative research culture that allows us to have the greatest possible impact on the community that we serve. Our strategic plan is a roadmap to realize this vision.

Key Research Centers

Americans with Disabilities Act Knowledge Translation Center (ADAKTC)

  The Knowledge Translation (KT) Center  supports the ADA National Network (ADANN)  in helping people with disabilities, professionals, employers, businesses, and others understand their rights and responsibilities under the Americans with Disabilities Act (ADA). The primary goal of the project, in collaboration with the ADANN, is to perform activities that increase the implementation of the ADA in communities across the United States.

University of Washington Department of Rehabilitation Medicine Research Burn Model System (BMS) National Data and Statistical Center

The center  is a centralized resource for researchers, data collectors, and clinicians within and beyond the BMS. Center researchers provide data collection and data management expertise, statistical and methodological assistance and services, access to the BMS National Longitudinal Database (BMS NDB), overviews of the data contained in the BMS NDB, and training and technical assistance to BMS Centers.

Center for Limb Loss and MoBility (CLiMB), VA

CLiMB has been continuously funded by VA RR&D since 1997, including more than $6 million in current center funding and approximately $30 million in investigator-initiated funding over the past five years. The center’s mission is to preserve, restore, and enhance functional mobility, independence, and participation in veterans with lower limb musculoskeletal impairment or limb loss. CLiMB principal investigators are scientists and clinician-scientists from the UW departments of Rehabilitation Medicine, Orthopedics, and Mechanical Engineering. CLiMB’s multidisciplinary team of principal investigators, staff, students, and postdocs focus on a range of scientific domains across the pathway, from basic science through clinical research and translation. 

CLEAR Center, University of Washington

The Clinical Learning, Evidence and Research (CLEAR) Center  is a musculoskeletal research center led by a multidisciplinary team at the University of Washington. Founded in 2017, the CLEAR Center is funded by an initial $3.75 million grant from the from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) .

Multiple Sclerosis Rehabilitation & Wellness Research Center 

This center  is a group of clinician-scientists committed to investigating novel interventions to help people with multiple sclerosis (MS) live their best lives while training the next generation of researchers and providers. Center clinician-scientists focus on innovative clinical research to improve the delivery and utilization of effective treatments for MS and comorbid conditions, including chronic pain, fatigue, and depression, to affect system-level changes to improve care for people living with MS.

Northwest Regional Spinal Cord Injury System (NWRSCIS) 

The NWRSCIS  is a regional center of spinal cord injury care, research, and education. The mission of the NWRSCIS is to improve the lives of people with SCI through excellent patient care, research, and education. The center provides specialized care to persons with SCI, conducts clinically relevant research, and disseminates the most useful, evidence-based information to people with SCI, their families, and professionals. Programs and services are provided at both the UWMC and HMC.

Traumatic Brain Injury (TBI) Model System, University of Washington

The UW TBI Model System  is one of 16 government-funded model system centers in the United States. Each center provides a multidisciplinary system of rehabilitation care, including emergency, acute, and post-acute services. The largest long-term study of people who have experienced TBI, the TBI Model System seeks to understand how people recover from brain injury and what health issues continue to persist. Center researchers recruit participants who are receiving inpatient care at HMC or UWMC.

Featured Research Areas

.css-jzm5km{display:block;-webkit-text-decoration:none;text-decoration:none;color:#000000;}.css-jzm5km:hover,.css-jzm5km:active,.css-jzm5km:focus{-webkit-text-decoration:underline;text-decoration:underline;} brain injury .css-1s3g6hp{display:block;max-width:56px;height:4px;background-color:#ffc700;border-radius:8px;margin-top:8px;}, burn rehabilitation, disability and community, limb absence, difference or dysfunction, multiple sclerosis, musculoskeletal/spine, spinal cord injury, additional research, researcher stories, research staff profile: erica wasmund, research staff profile: zoey chu, research staff profile: tyler barrett, research staff profile: malka dhillon, research staff profile: aaron flaster.

Baylor College of Medicine, University of Houston Awarded $44.2 million to Create Regional Hub for Translational Research

By Bryan Luhn — 713-743-0954

• Health and Medicine

Baylor College of Medicine and the University of Houston have been awarded a $44.2 million Clinical and Translational Science Award Program grant from the National Center for Advancing Translational Research to create a regional hub to serve as a support for infrastructure, services, community engagement and workforce development to advance research and drive innovation in clinical translational science.

Key Takeaways

• $44.2 million grant to BCM and UH establishes the Consortium for Translational and Precision Health, a regional hub to support clinical translational research. 
• The CTPH builds on the partnership between BCM, UH and other clinical and research groups within the Texas Medical Center to foster innovation in areas such as basic science, health services pharmaceutical sciences and entrepreneurship.  
• Hub will connect researchers with community health care organizations and government agencies, creating a multidisciplinary environment that supports infrastructure, services and workforce development to advance health care solutions. 
• The CTPH will provide funding and resources for pilot projects and research initiatives, helping to accelerate the translation of new technologies and discoveries into patient care and population-level impact. 
• Draws on expertise from 10 UH colleges, including medicine, nursing, pharmacy, optometry, engineering and others, highlighting the comprehensive institutional commitment to improving population health outcomes.

This new hub is called the Consortium for Translational and Precision Health (CTPH) and builds on the strong partnership between UH and BCM along with the clinical and research groups within the Texas Medical Center that collaborate with these two institutions. It draws on strengths from both institutions in basic science, translational research, health services, pharmaceutical sciences as well as entrepreneurship to develop and disseminate innovations. The CTPH also will connect investigators with community healthcare organizations and government agencies that contribute to healthcare, clinical research and policy in the region.

“This transformational grant for clinical research, led by Baylor and UH, will advance care for patients in Houston and beyond,” said Dr. Paul Klotman, president, CEO and executive dean of BCM. “It will accelerate the transfer of new technologies to patient care.”

“Research is the engine empowering health care’s life-changing advancements,” said UH President Renu Khator. “This innovative hub will be a catalyst for groundbreaking discoveries and treatments that improve people’s quality of life. That’s what drives us at UH and we’re ecstatic to cofound a regional hub for change alongside Baylor.”

The leaders for the CTPH are Dr. Christopher Amos, professor and director of the Institute for Clinical and Translational Research (ICTR) at BCM, Dr. Fasiha Kanwal, professor of medicine and chief of the section of gastroenterology and hepatology at BCM, and Dr. Bettina M. Beech, clinical professor of population health and the chief population health officer at UH.

“The CTPH is a partnership that draws on strengths of both institutions, creating a rich multidisciplinary environment. It will act as the vehicle to enhance the infrastructure and resources needed to effectively conduct research and implement solutions to advance healthcare,” said Dr. Carolyn Smith, interim senior vice president and dean of research at BCM. “It will help implement and create ongoing core research activities that will support the clinical translational science at both institutions.”

The hub will provide funding for pilot projects, and support the groundwork needed for ongoing research. For example, a researcher developing a clinical study might need help with community outreach and engagement, additional study design planning, or access to clinical data. The CTPH will provide resources and services to accelerate the pace of research from discovery to population level impact.

The foundational platform for the CTPH has been laid out in part by the work of Amos’ group at ICTR, which is a group that supports clinical and translational research within BCM.

In addition to UH’s Population Health program and Division of Research, the CTPH will draw upon expertise from 10 UH colleges, including the Tilman J. Fertitta Family College of Medicine, Andy & Barbara Gessner College of Nursing, College of Pharmacy, College of Optometry, C. T. Bauer College of Business, Cullen College of Engineering, College of Natural Sciences and Mathematics, College of Education, College of Liberal Arts and Social Sciences, and the Honors College.

“We are deeply committed to advancing innovation in clinical and translational science, and this award is a significant step forward in our mission to improve population health outcomes,” Beech said. “This is a testament to the unwavering dedication and collaborative spirit of everyone involved. It truly was a team effort.”

Currently, more than 60 leading medical institutions across the nation receive CTSA Program funding. The institutions offer expertise, resources and partnerships at the national and local levels to improve the health of individuals and communities. The CTSA Program also nurtures the field of translational science through education, training and career support at all levels.

Top Stories

August 22, 2024

New UH/TSU Survey Finds Trump’s Lead Among Likely Texas Voters is Narrowing

A new UH/TSU survey finds nearly half of Texans plan to vote for former Republican President Donald Trump in November, while 44.6% support the Democratic nominee, Vice President Kamala Harris. That’s notably tighter than the nine-point lead Trump held over President Joe Biden in an earlier survey.

• Policy, Law and Government

August 17, 2024

Eddie Nuñez Named Vice President for Intercollegiate Athletics

Eddie Nuñez has been named Vice President for Intercollegiate Athletics at the University of Houston, joining the Cougars after successfully holding leadership positions at the University of New Mexico and LSU.

• University and Campus

August 15, 2024

University of Houston Students Shine in Amazon Prime’s “The College Tour”

The University of Houston will be streaming into homes and on devices across America this fall. UH is featured in a 30-minute episode of the acclaimed Amazon Prime Video series “The College Tour.”

• Appointments
• Our Providers
• For Physicians
• Survivorship Program

For many cancer survivors, both the disease and treatment have long-lasting or late-onset effects. Our Fred Hutch Survivorship Program offers support, consultation and education for years after cancer treatment is over. 

The Survivorship Program enables survivors to take an active role in their renewed health and teaches them how to educate their family members and healthcare team about their needs.

Clinical Care

We offer a Survivorship Clinic to help survivors understand their cancer diagnosis and treatment, address the chronic effects of cancer and its therapy, provide monitoring recommendations to allow for early identification of treatment-related sequelae and promote health-protective behaviors.

Events and Education

Education and community are important aspects of life as a cancer survivor. We host events and lectures throughout the year for cancer patients, survivors, caregivers, friends, family, and health care professionals.

These events share our expertise and provide educational opportunities to healthcare providers working with patients after cancer treatment. Opportunities include continuing medical education and publications and presentations on current survivorship issues.

Survivorship research being conducted at Fred Hutch, University of Washington, and Seattle Children’s examines and addresses the long- and short-term physical, psychological, social and economic effects of cancer and its treatment. Studies can involve survivors themselves as well as care givers and family members. 

As part of our research program, all patients entering survivorship care complete questionnaires about their physical, emotional and medical experiences. We use these surveys to determine eligible survivors and invite them to participate in research projects.

Survivorship Program Staff

Scott Baker, M.D.

Dr. Baker joined the Survivorship Program as director in February of 2009. He works with pediatric bone marrow transplant patients and also leads the pediatric survivorship program at Seattle Children’s.

Sheri Ballard, M.P.H.

Ms. Ballard is a project manager for the Survivorship Program. She manages research studies for adolescent and young adult cancer survivors.  

Joli Bartell, B.S.

Ms. Bartell is the project coordinator for outreach activities and events for the Survivorship Program.

Neel Bhatt, M.D., M.B.B.S., M.P.H.

Dr. Bhatt is a pediatric hematologist-oncologist. He is an expert in cancer survivorship and cares for adult long-term survivors of pediatric cancer and transplantation. 

Eric Chow, M.D., M.P.H.

Dr. Chow serves as the co-director of the Survivorship Program. He sees pediatric cancer survivors at Seattle Children’s and also adult long-term survivors of pediatric cancer at Fred Hutch. 

Lauren Clarke Beaber

Ms. Clarke Beaber is a clinical research coordinator for the Survivorship Program. She coordinates studies for pediatric and adult cancer survivors. 

Debra Loacker, R.N.

Ms. Loacker joined the Survivorship Program in March of 2009. She creates the patient treatment summaries and supports the nurse practitioners by providing lab and test results.

Emily Jo Rajotte, M.P.H.

Ms. Rajotte began her work with the Center in 2005. As Program Operations Director, her work includes writing grant applications, launching new clinical services and collaborating with other organizations.

Barbara Regis, PA-C

Ms. Regis is certified physician assistant who sees patients at the South Lake Union Clinic. She provides care in the Survivorship Clinic and sees patients who have completed treatment and moved into surveillance of their condition or who are past surveillance and are now trying to figure out how to live their best life after treatment.

LIVESTRONG at The YMCA

Since 2008, LIVE STRONG  at the YMCA has been a safe, comfortable place for participants to build companionship with others affected by cancer and share stories and inspiration.

During the 12-week program, participants meet twice a week for 90 minutes. They use traditional exercise methods to ease back into fitness and help maintain a healthy weight. Topics include:

• Building muscle mass and strength
• Increasing flexibility and endurance
• Improving confidence and self-esteem

Participants also learn about wellness, stress reduction techniques and how to continue healthful habits after the program has ended. 

National Cancer Care Resources

American Cancer Society Source for news, information, and support.

Cancer Care The oldest and largest nonprofit agency offering cancer support and information.

Cancer Hope Network One-on-one patient and family support.

LIVESTRONG Foundation Cancer awareness, education, and support.

Leukemia and Lymphoma Society Research, education and patient services for all blood cancers.

National Cancer Institute (NCI) Free resources and materials for all cancer types.

National Coalition of Cancer Survivorship Advocating for quality cancer care and empowering survivors.

National Institutes of Health (NIH) Health information and resources.

Survivorship Care for Healthy Living National Comprehensive Cancer Network (NCCN) Guidelines for Patients

Survivorship for Cancer-Related Late and Long-Term Effects National Comprehensive Cancer Network (NCCN) Guidelines for Patients

Washington State Cancer Care Resources

Cancer Lifeline Programs, support groups, classes, activities and presentations aimed at optimizing the quality of life for cancer patients and cancer survivors and their families, friends, co-workers and caregivers.

Crisis Line of Seattle 206.461.3222

Cancer Pathways Free support and networking groups, lectures, workshops and social events in a nonresidential, home-like setting.

Team Survivor Northwest A broad range of fitness and health education programs to enable women cancer survivors, in any stage of treatment or recovery and at any fitness level.

Washington State Office of the Insurance Commissioner 800.562.6900 Free assistance and education to consumers regarding insurance questions, including the authority to investigate formal complaints against insurers and agents, and enforce insurance law.

Contact the Survivorship Program

Mailing Address

Fred Hutch Cancer Center PO Box 19024, Mail stop LF-268 Seattle, WA 98109 To schedule a clinic appointment, call 206.606.6100 and ask to schedule with the Survivorship Clinic or email the clinic at [email protected] .

• Fred Hutchinson Cancer Center

• Research Impact
• Hubs and Working Groups
• Facts and Figures
• Historical Timeline
• Internal Funding for Researchers
• Limited Submissions
• External Funding (PIVOT)
• Faculty Research Resources
• Grant Preparation and Support
• Human Research Protection Program/Institutional Review Board
• Environmental Health and Safety
• Institutional Animal Care & Use Committee
• Research Administration Units
• Policies and Guidelines
• The Research Post Updates
• Research News (Innovate U)
• Leadership and Staff
• Organization Chart
• Administration Units
• Advisory Committees

Vice President for Research

Request for applications: 2025-2026 scholar cohort of the vice president’s clinical & translational (vpcat) research scholars program.

Important Dates

• Virtual VPCAT Application Workshop : Friday, August 30, 2024 from 4:00-5:00 pm; to register, email Erin Wachs
• Online Application Due Date : Friday, September 27, 2024 by 5:00 pm MST via Competition Space (no late applications accepted)

We are inviting junior faculty committed to clinical or translational research careers to apply for the 2025-2026 Cohort of the Vice President’s Clinical and Translational ( VPCAT ) Research Scholars Program . The VPCAT Program is a competitive, 2-year mentoring program that offers intensive mentorship and support to primarily Instructor or Assistant Professor-level faculty members from all colleges and schools within the Health Sciences and the Colleges of Mines & Earth Sciences, Social & Behavioral Science, and Social Work. Interested applicants who are not members of the colleges mentioned earlier should contact Erin Wachs regarding eligibility.

VPCAT leverages institutional resources to augment departmental and college resources in support of junior faculty engaged in clinical and translational research using a multi-level Matrix Mentoring Model that includes self, scientific, peer, senior, and staff mentorship. A mentoring team consisting of a scientific mentor, a VPCAT senior mentor, peer mentors, and staff mentors support each VPCAT scholar. VPCAT has a structured curriculum that provides leadership competencies and essential knowledge and practical skills to be an effective principal investigator. In addition, VPCAT supports scholars’ access to the Utah Clinical and Translational Science Institute’s Translational Research: Implementation, Analysis, & Design (TRIAD) Cores, educational opportunities, and a senior research manager. These resources facilitate appropriate study design, pilot data collection, and preparation/submission of highly competitive grant applications.

A prospective VPCAT scholar should be engaged in clinical and translational research and aspire to achieve research independence as a principal investigator. VPCAT expects applicants to have a clearly defined research interest, an identified scientific mentor, and a plan to apply for extramural funding during their program tenure. Ideal candidates are early-stage faculty beyond their 1 st year at their institution, with preferably one or more original research publications with their scientific mentor. For more information and tips for writing an excellent application, we are holding a virtual VPCAT Application Workshop for eligible prospective applicants on Friday, August 30, 2024 from 4:00-5:00 pm . To register, email Erin Wachs .

Please visit our website for further details, including applicant eligibility criteria, instructions, review criteria, example applications, and program overviews and requirements. All applications are due by Friday, September 27, 2024, at 5:00 pm MST via Competition Space , and we will not accept late applications. Over October 2024, VPCAT senior mentors and VPCAT Alumni Advisory Board members review and score applications adhering to our review criteria. We release selection notifications by November 1, 2024. All accepted applicants must attend the mandatory in-person 1 ½-day VPCAT Orientation and Capstone on Monday, December 9, 2024 and Tuesday, December 10, 2024. On the evening of Monday, December 9, 2024 from 6:00-9:00 pm, we will host the VPCAT Soirée at Red Butte Garden’s Richard K. Hemingway Orangerie. Scholars begin the program on January 1, 2025, and graduate as of December 31, 2026.

If you have questions about the VPCAT Program or faculty eligibility, please email Erin Wachs or the VPCAT Director, Dr. Michael Rubin .

Department of Molecular Biology

Biochemistry, Biophysics & Structural Biology

Biochemistry and Biophysics are the foundation of all cellular processes and systems. Biochemical processes account for the functions of cellular building blocks, from nucleic acids and proteins to lipids and metabolites, and the formation of complex networks that make a cell or system work. Biophysics explains the complexity of life with the simplicity of physical laws and math.

The mission of our collaborative unit ‘Biochemistry & Biophysics’ is to train the next generation of scientists and to uncover how life works at the molecular level. Our scientists study macromolecular complexes and their specificity, protein design and evolution, and molecular networks. We illuminate how the cytoskeleton determines cell shape, how cells transduce signals, how membranes fuse, how chromatin organizes the genome, how metabolism is coordinated, how viruses hijack cells, how the immune response works, and how cells form patterns and communicate with each other.

We are experts in bioengineering, structural biology, computation and modeling, optics and microscopy, and microfluidics. Some examples of the approaches being used, and in some cases developed, at Princeton include X-ray crystallography, electron microscopy, mass spectrometry, NMR spectroscopy, super-resolution optical microscopy, single-molecule methods, and computational modeling. These tools are being applied to biological problems ranging from protein folding and design, to signal transduction, to intracellular trafficking.

A long-standing tradition and strength of our University is that biologists, chemists and physicists work closely together in an interdisciplinary setting. It is also common to see computational biologists working together with wet-lab biologists to address problems that neither could tackle alone with spectacular results. This is facilitated by the intimate connection between the Department of Molecular Biology with the Departments of Chemistry , Physics and Chemical and Biological Engineering , as well at the Lewis-Sigler Institute for Integrative Genomics

Associated Faculty

• Moscow Oblast
• Hotels with Suites

Hotels with Suites in Boltino available. Book today!

Boltino hotels & places to stay in boltino.

• Air Conditioner
• Pet Friendly
• North-Eastern Administrative Okrug

• Central Russia
• Chelyuskinsky

• Wheelchair Accessible

About Boltino Hotels with Suites on Rent By Owner

Can't find a Rent By Owner or vacation rental in Boltino, RU? We have many Hotel Suites in Boltino, from budget to luxury, to suit your needs as well.

Our site boasts of more than 6 hotels listings near Boltino. Whether you are going on a business trip, leisure vacation with a group, or traveling with your family or friends for summer or winter break, there’s always something perfect for you.

If you want to experience a great trip, we have thousands of hotels, resorts, or motels with updated prices for 2024. RBO hotels in top destinations are available for last-minute booking deals, including top brand hotel chains such as Radisson Hotel, OYO, Marriott, Hyatt, Hilton, MGM Resorts, & more.

Top recommendations in Istra

New Jerusalem Monastery

Visit the New Jerusalem Monastery, its magnificent walls and the amazing Resurrection Cathedral.

Plan your next trip to Russia

Ready-to-book tours.

Your holiday in Russia starts here. Choose and book your tour to Russia.

REQUEST A CUSTOMISED TRIP

Looking for something unique? Create the trip of your dreams with the help of our experts.